Regional Business Manager - Northern California

IntelliaCambridge, MA
Remote

About The Position

We are seeking an exceptional Sales Representative to lead the commercial launch of our groundbreaking in vivo CRISPR therapy for hereditary angioedema (HAE). This role represents a career defining opportunity to pioneer the commercialization of the first-ever, single treatment gene editing therapy. The successful candidate will be responsible for introducing healthcare providers to the first-ever in vivo CRISPR therapy, requiring sophisticated scientific communication, complex stakeholder management, and exceptional execution within a highly competitive rare disease market. This territory will cover Northern California.

Requirements

  • Comprehensive knowledge of hereditary angioedema pathophysiology, treatment landscape, and unmet medical needs
  • Understanding of gene editing technologies, genetic medicines, and regulatory requirements
  • Ability to analyze and present complex clinical trial data and real-world evidence
  • Exceptional ability to communicate complex scientific concepts to diverse healthcare audiences
  • Proven ability to build and maintain long-term relationships with key stakeholders
  • Creative approach to overcoming access barriers and treatment implementation challenges
  • Nurtures internal relationships and facilitates collaboration to establish trust and support from others.
  • Remain open to change and demonstrates a willingness to try new approaches to achieve better results
  • Engages in bold conversations, handles objections, and asks for the business
  • Demonstrates a business owner mindset and takes action to exceed expectations. Develops and executes on a comprehensive business plan to maximize customer and patient impact
  • Passion for pioneering new treatment paradigms and improving patient outcomes
  • Ability to persist through lengthy sales cycles and overcome technology-related objections
  • Flexibility to adjust strategies based on market feedback and competitive dynamics
  • Unwavering commitment to ethical sales practices and regulatory compliance
  • Genuine commitment to improving lives of patients with rare genetic diseases
  • BS/BA in life sciences or a business-related field
  • 5+ years of specialty pharmaceutical sales experience, preferably in rare diseases, immunology, or genetic medicines
  • Proven track record in rare disease commercialization with complex treatment paradigms and small patient populations
  • Previous experience with product launches, particularly first-in-class or novel mechanism therapies
  • Demonstrated success in long sales cycles (12-18 months) with multiple stakeholders and high-value transactions

Nice To Haves

  • Rare Disease, Gene therapy, and HAE market knowledge preferred but not necessary

Responsibilities

  • Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers
  • Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
  • Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
  • Maintain robust sales pipeline tracking opportunities from initial awareness through patient treatment completion
  • Educate healthcare providers on in vivo CRISPR gene editing mechanisms, differentiating from ex vivo cell therapies and traditional treatments
  • Clearly articulate the unique mechanism of action compared to prophylactic treatments, complement inhibitors, and plasma-derived therapies
  • Present Phase III efficacy and safety data
  • Address misconceptions about CRISPR safety and differentiate from previous gene therapy launches
  • Educate healthcare providers about unmet needs affecting disease management and treatment burden
  • Maintain deep understanding of competitive landscape and emerging therapies
  • Articulate differentiated value propositions versus existing HAE treatments and other gene therapies
  • Proactively address concerns about CRISPR technology, permanent genetic modification, and single-treatment cost
  • Position organization as innovative leader with superior clinical acumen
  • Educate on the patient pathway from diagnosis confirmation through treatment administration
  • Coordinate with patient support hubs to ensure seamless patient experience and treatment access
  • Coordinate with Medical Science Liaisons to seamlessly address customers’ medical and clinical informational needs
  • Work closely with Field Reimbursement Managers on payer strategy and coverage optimization
  • Partner with strategic accounts team to understand referral patterns, site selection, and site activation for procurement and administration of the therapy

Benefits

  • performance-based annual cash bonus
  • new hire equity grant
  • eligibility to be considered for annual equity awards
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service